Press release
Unlocking Opportunities in the Autologous Stem Cell And Non-Stem Cell Based Therapies Market: 2025-2034 Forecast Report
Autologous Stem Cell And Non-Stem Cell Based Therapies
What Will the Autologous Stem Cell And Non-Stem Cell Based Therapies Industry Market Size Be by 2025?
In recent years, there has been a swift expansion in the market size of autologous stem cell and non-stem cell based therapies. Growth is projected from $9.96 billion in 2024 to $11.59 billion in 2025, maintaining a compound annual growth rate (CAGR) of 16.5%. The considerable growth observed in the past can be ascribed to factors such as a notable increase in cancer and diabetes cases, a larger population of elderly individuals, heightened healthcare awareness, a surge in research and developmental actions, an upswing in the number of clinical trials, and an increase in regulatory approvals.
What's the Long-Term Growth Forecast for the Autologous Stem Cell And Non-Stem Cell Based Therapies Market Size Through 2029?
Predictions indicate a significant surge in the autologous stem cell and non-stem cell based therapies industry in the forthcoming years, with the market expected to reach a size of $21.07 billion in 2029, growing at a compound annual growth rate of 16.1%. This anticipated expansion during the forecast period may be influenced by factors such as a higher incidence of specific diseases, a rising elderly population and an increase in neurodegenerative illnesses. The growing prevalence of different cancer types, a rising need for skin graft procedures, improved public knowledge about regenerative treatments and cooperative endeavors between leading industry figures may also contribute. Moreover, improved financial coverage policies for approved treatments is also a contributing factor. The forecast period will also see trends such as the utilization of artificial intelligence and machine learning, the creation of ready-to-use allogeneic stem cell goods, widening of reimbursement policies, use of innovative biomaterials, enhancements in cell production technologies, adoption of autologous stem cell treatments and the incorporation of gene editing techniques.
View the full report here:
https://www.thebusinessresearchcompany.com/report/autologous-stem-cell-and-non-stem-cell-based-therapies-global-market-report
What Are the Key Growth Drivers Fueling the Autologous Stem Cell And Non-Stem Cell Based Therapies Market Expansion?
The autologous stem cell and non-stem cell-based therapies market is projected to experience significant growth due to the increasing need for personalized treatments. These therapies are crafted to maximize the benefits and reduce the side effects based on each patient's unique genetic makeup, lifestyle, and preferences. The growth in demand for tailored care options can be attributed to several factors, including advancements in genetics and technology that allow for more accurate and effective treatments with fewer side effects, escalating patient demand for bespoke care, and the potential for healthcare cost reductions. These personalized therapies enhance the implementation of autologous stem cell and non-stem cell-based treatments by adjusting them to match an individual's unique genetic and health characteristics, resulting in improved results and fewer complications. For instance, the Personalized Medicine Coalition, a professional membership organization based in the US, revealed that 12 new personalized medicine approvals in 2022 accounted for approximately 34% of all newly approved therapies, demonstrating a considerable increase from prior years. Hence, the autologous stem cell and non-stem cell-based therapies market is being driven by the rising demand for personalized therapies.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15729&type=smp
What Are the Key Trends Driving Autologous Stem Cell And Non-Stem Cell Based Therapies Market Growth?
Leading organizations operating in the autologous stem cell and non-stem cell based therapies sector are innovating tumor-derived autologous T cell immunotherapy to advance individualized cancer treatments. This method of immunotherapy involves procuring T cells from a patient's tumor, amplifying and priming them in a laboratory environment, and re-administering them to the patient with the aim of bolstering the immune system's capability to identify and eradicate cancer cells in a specific manner. For example, in February 2024, Iovance Biotherapeutics, an American biotech firm, was granted expedited approval by the Food and Drug Administration, an American federal agency, for the use of Amtagvi (lifileucel). This is the inaugural cellular therapy designed for treating adult patients suffering from melanoma. Lifileucel is an autologous T-cell immunotherapy sourced from a tumor. It consists of a patient's naturally occurring immune cells, known as tumor-infiltrating lymphocytes (TILs), enhancing the patient's immune system's ability to identify and combat the cancer more efficiently.
How Is the Autologous Stem Cell And Non-Stem Cell Based Therapies Market Segmented?
The autologous stem cell and non-stem cell based therapies market covered in this report is segmented -
1) By Type: Autologous Stem Cells, Autologous Non-Stem Cells, Other Types
2) By Application: Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Research Facilities, Other End Users
Subsegments:
1) By Autologous Stem Cells: Hematopoietic Stem Cells, Mesenchymal Stem Cells, Neural Stem Cells, Endothelial Stem Cells
2) By Autologous Non-Stem Cells: Platelet-Rich Plasma (Prp), Adipose-Derived Cells, Peripheral Blood Cells
3) By Other Types: Exosome-Based Therapies, Tissue-Engineered Constructs
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15729&type=smp
Which Companies Are Leading the Charge in Autologous Stem Cell And Non-Stem Cell Based Therapies Market Innovation?
Major companies operating in the autologous stem cell and non-stem cell based therapies market are Bayer AG, Novartis AG, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Merck & Co. Inc., Stemcell Technologies Inc., Dendreon Corporation, Vericel Corporation, Sangamo Therapeutics Inc., NEOSTEM, Orgenesis Inc., Adaptimmune Therapeutics, Stempeutics Research Pvt Ltd., MEDIPOST, Castle Creek Biosciences Inc., BrainStorm Cell Limited, Athersys Inc., Cytori Therapeutics Inc., Opexa Therapeutics, Gamida Cell, Regen BioPharma Inc., RepliCel Life Sciences, InGeneron Inc., BioCardia Inc., ReNeuron Group
Which Regions Are Leading the Global Autologous Stem Cell And Non-Stem Cell Based Therapies Market in Revenue?
North America was the largest region in the autologous stem cell and non-stem cell based therapies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous stem cell and non-stem cell based therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15729
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Unlocking Opportunities in the Autologous Stem Cell And Non-Stem Cell Based Therapies Market: 2025-2034 Forecast Report here
News-ID: 4130920 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
